Nanoforming Hyaluronan-Based Thermoresponsive Hydrogels: Optimized and Tunable Functionality in Osteoarthritis
Alexandre Porcello1,2, Paula Gonzalez-Fernandez1,2, Olivier Jordan1,2
1School of Pharmaceutical Sciences, University of Geneva, CH-1206 Geneva, Switzerland.
Pharmaceutics
|March 26, 2022
Summary
Novel hyaluronic acid (HA) nanoparticles offer improved osteoarthritis pain relief. These thermoresponsive HA derivatives resist degradation and provide better joint lubrication, showing potential as advanced viscosupplementation treatments.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Rheumatology
Background:
- Hyaluronic acid (HA) is a key component in viscosupplementation for osteoarthritis (OA) pain.
- Current HA treatments face limitations due to rapid in vivo degradation by enzymes and oxidative stress.
- There is a need for advanced HA formulations with prolonged residence time and enhanced functionality.
Purpose of the Study:
- To develop novel thermoresponsive, nanoforming hyaluronic acid derivatives for improved viscosupplementation.
- To engineer HA-based polymers with enhanced viscoelastic properties and in vivo stability.
- To evaluate the potential of these advanced HA systems as next-generation OA treatments.
Main Methods:
- Synthesis of HA-based polymers using sulfo-dibenzocyclooctyne-PEG4-amine linkers and poly(N-isopropylacrylamide) via green chemistry.
- Characterization of thermoresponsive nanoparticle formation above 30 °C.
- In vitro assessment of degradation resistance (enzymatic and oxidative) and viscoelastic properties.
Main Results:
- Successfully synthesized thermoresponsive HA-PEG-PNIPAM nanoparticles with tunable viscoelastic properties.
- Demonstrated spontaneous and reversible nanoparticle formation above 30 °C.
- Achieved significantly enhanced in vitro resistance to enzymatic and oxidative degradation compared to commercial HA.
- Observed optimal viscoelastic hydrogel properties and reduced injection force in equine synovial fluid.
Conclusions:
- Engineered HA derivatives show promise as long-acting viscosupplementation agents.
- The developed thermoresponsive nanoparticles offer a potential breakthrough for osteoarthritis pain management.
- These advanced HA-based systems represent a next-generation approach to viscosupplementation therapy.


